ArticleNeoplasia (New York, N.Y.)2007

Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.

Edmond Auzenne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.